0001144204-19-015666.txt : 20190322
0001144204-19-015666.hdr.sgml : 20190322
20190322184834
ACCESSION NUMBER: 0001144204-19-015666
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190315
FILED AS OF DATE: 20190322
DATE AS OF CHANGE: 20190322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CGI Cellerate RX, LLC
CENTRAL INDEX KEY: 0001766396
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 19701021
BUSINESS ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
BUSINESS PHONE: 512-320-8600
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Catalyst Rochal, LLC
CENTRAL INDEX KEY: 0001766398
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 19701022
BUSINESS ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
BUSINESS PHONE: 512-320-8600
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gurasich Bradley J.
CENTRAL INDEX KEY: 0001766399
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 19701023
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0000714256
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 592220004
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817-529-2300
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
FORMER COMPANY:
FORMER CONFORMED NAME: MB SOFTWARE CORP
DATE OF NAME CHANGE: 19960805
FORMER COMPANY:
FORMER CONFORMED NAME: INAV TRAVEL CORPORATION
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: TWISTEE TREAT CORP
DATE OF NAME CHANGE: 19910220
3
1
tv516868_3.xml
OWNERSHIP DOCUMENT
X0206
3
2019-03-15
0
0000714256
WOUND MANAGEMENT TECHNOLOGIES, INC.
WNDM
0001766396
CGI Cellerate RX, LLC
1375 ENCLAVE PARKWAY
HOUSTON
TX
77077
0
0
1
0
0001766398
Catalyst Rochal, LLC
1375 ENCLAVE PARKWAY
HOUSTON
TX
77077
0
0
1
0
0001766399
Gurasich Bradley J.
7500 RIALTO BLVD BUILDING II, SUITE 220
AUSTIN
TX
78735
0
0
1
0
Series F Convertible Preferred Stock
Common Stock
227363000
D
5% Convertible Promissory Note
0.09
2019-08-28
2021-03-01
Common Stock
16959339
D
Reflects 1,136,815 shares of Series F Convertible Preferred Stock ("Convertible <0x200E>Preferred Stock") owned of record by CGI Cellerate RX, LLC that are immediately convertible into 237,363,000 shares of Common Stock with equivalent <0x200E>voting rights. The Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Convertible Preferred Stock. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.
The Convertible Preferred Stock is convertible at on a 200 for 1 basis into fully paid and nonassessable shares of the Issuer's Common Stock.
Reflects a $1,500,000.00 Convertible Promissory Note ("Note") from Wound Management Technologies, Inc. ("Issuer") to CGI Cellerate RX, LLC convertible into 16,959,339 shares of common stock of the Issuer at $0.09 per share as of December 31, 2018. CGI Cellerate RX, LLC is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virtue of these relationships, CGI Cellerate RX, LLC, Catalyst Rochal, LLC and, Mr. Gurasich may be deemed to share voting and dispositive control over the Common Stock issuable upon the conversion of the Note. Catalyst Rochal, LLC and Mr. Gurasich disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.
CGI CELLERATE RX, LLC, /s/ Ron Nixon and /s/ Brad Gurasich
2019-03-21
CATALYST ROCHAL, LLC, /s/ Ron Nixon and /s/ Brad Gurasich
2019-03-21
/s/ Brad Gurasich
2019-03-21